Interleukin-18 Is a Prognostic Biomarker Correlated with CD8(+) T Cell and Natural Killer Cell Infiltration in Skin Cutaneous Melanoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gil, Minchan | - |
dc.contributor.author | Kim, Kyung Eun | - |
dc.date.available | 2021-02-22T05:45:27Z | - |
dc.date.issued | 2019-11 | - |
dc.identifier.issn | 2077-0383 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/2755 | - |
dc.description.abstract | Interleukin-18 (IL-18) is a cytokine that enhances innate and adaptive immune responses. Although there are conflicting reports about the roles of IL-18 in melanoma progression, the clinical relevance of IL-18 expression has not been comprehensively studied. In this study, we investigated IL-18 expression and its correlation with patient survival and immune cell infiltration in melanoma using cancer gene expression data publicly available through various databases. IL18 mRNA expression was found to be significantly lower in melanoma tissues than normal tissues. Kaplan-Meier survival analysis showed that IL18 expression was positively correlated with patient survival. To investigate the possible mechanisms by which IL18 expression increased patient survival, we then assessed the correlation between IL18 expression and immune cell infiltration levels. Infiltration of various immune cells, especially CD8(+) T and natural killer (NK) cells, which are cytolytic effector cells, was significantly increased by IL18 expression. Additionally, the expression levels of two cytolytic molecules including perforin and granzyme B were significantly positively correlated with IL18 expression. Collectively, this study provides the first evidence that IL18 expression has prognostic value for melanoma patient survival and is strongly correlated with CD8(+) T and NK cell infiltration, suggesting the role of IL-18 as a biomarker for predicting melanoma prognosis. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI AG | - |
dc.title | Interleukin-18 Is a Prognostic Biomarker Correlated with CD8(+) T Cell and Natural Killer Cell Infiltration in Skin Cutaneous Melanoma | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/jcm8111993 | - |
dc.identifier.scopusid | 2-s2.0-85086779645 | - |
dc.identifier.wosid | 000502294400236 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Medicine, v.8, no.11 | - |
dc.citation.title | Journal of Clinical Medicine | - |
dc.citation.volume | 8 | - |
dc.citation.number | 11 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | NK CELLS | - |
dc.subject.keywordPlus | GAMMA PRODUCTION | - |
dc.subject.keywordPlus | IMMUNE CELLS | - |
dc.subject.keywordPlus | SERUM-LEVELS | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | IL-18 | - |
dc.subject.keywordPlus | LYMPHOCYTES | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | REGRESSION | - |
dc.subject.keywordAuthor | Interleukin-18 | - |
dc.subject.keywordAuthor | melanoma | - |
dc.subject.keywordAuthor | immune infiltrates | - |
dc.subject.keywordAuthor | patient survival | - |
dc.subject.keywordAuthor | multiomic analysis | - |
dc.identifier.url | https://www.mdpi.com/2077-0383/8/11/1993 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.